Search Results - Roger Stupp

Refine Results
  1. 1
    Integrin Inhibitors Reaching the Clinic

    Integrin Inhibitors Reaching the Clinic by Roger Stupp, Curzio Rüegg

    Published 2007
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  2. 2
    Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

    Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up by Roger Stupp, Fausto Roila

    Published 2009
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Withholding temozolomide in glioblastoma patients with unmethylated<i>MGMT</i>promoter—still a dilemma?: Table 1.

    Withholding temozolomide in glioblastoma patients with unmethylated<i>MGMT</i>promoter—still a dilemma?: Table 1. by Monika E. Hegi, Roger Stupp

    Published 2015
    Get full text Get full text
    Editorial
    Save to List
    Saved in:
  4. 4
    Epilepsy meets cancer: when, why, and what to do about it?

    Epilepsy meets cancer: when, why, and what to do about it? by Michael Weller, Roger Stupp, Wolfgang Wick

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Standards of care and novel approaches in the management of glioblastoma multiforme

    Standards of care and novel approaches in the management of glioblastoma multiforme by Andreas F. Hottinger, Roger Stupp, Krisztián Homicskó

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Tumor treating fields: a novel treatment modality and its use in brain tumors

    Tumor treating fields: a novel treatment modality and its use in brain tumors by Andreas F. Hottinger, Patrícia Pacheco, Roger Stupp

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Are Integrins Still Practicable Targets for Anti-Cancer Therapy?

    Are Integrins Still Practicable Targets for Anti-Cancer Therapy? by Begoña Alday-Parejo, Roger Stupp, Curzio Rüegg

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Biological activity of tumor-treating fields in preclinical glioma models

    Biological activity of tumor-treating fields in preclinical glioma models by Manuela Silginer, Michael Weller, Roger Stupp, Patrick Roth

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Cilengitide: an integrin-targeting arginine–glycine–aspartic acid peptide with promising activity for glioblastoma multiforme

    Cilengitide: an integrin-targeting arginine–glycine–aspartic acid peptide with promising activity for glioblastoma multiforme by David A. Reardon, Burt Nabors, Roger Stupp, Tom Mikkelsen

    Published 2008
    Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Roger Stupp, Joerg‐Christian Tonn, M. Brada, George Pentheroudakis

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Individualized Targeted Therapy for Glioblastoma

    Individualized Targeted Therapy for Glioblastoma by Michael Weller, Roger Stupp, Monika E. Hegi, Wolfgang Wick

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    “Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma”

    “Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma” by Roger Stupp, Warren Mason, Martin J. van den Bent

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Recent developments in the use of chemotherapy in brain tumours

    Recent developments in the use of chemotherapy in brain tumours by Martin J. van den Bent, Monika E. Hegi, Roger Stupp

    Published 2006
    Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Performance of <sup>18</sup>F-Fluoro-Ethyl-Tyrosine (<sup>18</sup>F-FET) PET for the Differential Diagnosis of Primary Brain Tumor: A Systematic Review and Metaanalysis

    Performance of <sup>18</sup>F-Fluoro-Ethyl-Tyrosine (<sup>18</sup>F-FET) PET for the Differential Diagnosis of Primary Brain Tumor: A Systematic Review and Metaanalysis by Vincent Dunet, Christine Rossier, Alfred Buck, Roger Stupp, John O. Prior

    Published 2012
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Bevacizumab and Recurrent Malignant Gliomas: A European Perspective

    Bevacizumab and Recurrent Malignant Gliomas: A European Perspective by Wolfgang Wick, Michael Weller, Martin J. van den Bent, Roger Stupp

    Published 2010
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  16. 16
    Effect of computerisation on the quality and safety of chemotherapy prescription

    Effect of computerisation on the quality and safety of chemotherapy prescription by M. Voeffray, A. Pannatier, Roger Stupp, Nadia Fucina, Serge Leyvraz, JB Wasserfallen

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study

    Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study by Andrea O. Rossetti, Sandrine Jeckelmann, Jan Nový, Patrick Roth, Michael Weller, Roger Stupp

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Roger Stupp, M. Brada, Martin J. van den Bent, J.-C. Tonn, George Pentheroudakis

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    NT-40 * Interim Analysis of the EF-14 Trial: A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM

    NT-40 * Interim Analysis of the EF-14 Trial: A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients with Newly Diag... by Roger Stupp, ET Wong, C. Scott, Sophie Taillibert, Andrew A. Kanner, Santosh Kesari, Zvi Ram

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro

    Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro by Gabriele D. Maurer, Isabel Tritschler, Barbara J. Adams, Ghazaleh Tabatabai, Wolfgang Wick, Roger Stupp, Michael Weller

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: